Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms

Background: Intraductal papillary mucinous neoplasm (IPMN) can lead, via the adenoma–carcinoma sequence, to invasive adenocarcinoma, which has a poor prognosis. Most IPMNs do not meet the indications for surgery and instead are monitored regularly, but no biomarkers of malignant transformation during surveillance have been established. Patients and Methods: A total of 50 patients with IPMN who underwent pancreatectomy were evaluated retrospectively. Clinicopathological parameters during the surveillance period before surgery were assessed to explore biomarkers for predicting malignancy. Results: The serum level of carbohydrate antigen 19-9 was significantly higher in IPMN-derived invasive adenocarcinoma. The neutrophil-to-lymphocyte ratio was significantly lower in low-grade IPMN than high-grade and Inv-IPMN cases by univariate and multivariate analysis. Disease-free survival was significantly shorter in patients with high-grade and invasive IPMN compared with those with low-grade IPMN. In patients whose preoperative surveillance was performed for more than 12 months, the neutrophil-to-lymphocyte ratio was significantly higher in those with high-grade and invasive IPMNs compared with patients with low-grade IPMN in the year before surgery. Conclusion: The NLR is a useful biomarker for distinguishing between low-grade and high-grade IPMN and thus should be monitored during surveillance.

[1]  Haibin Song,et al.  Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer , 2020, Journal of immunology research.

[2]  elliot k fishman,et al.  Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines , 2019, Nature Reviews Gastroenterology & Hepatology.

[3]  Jeong Ah Hwang,et al.  Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines. , 2019, Radiology.

[4]  M. Makary,et al.  Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. , 2019, Annals of surgery.

[5]  N. Nishizawa,et al.  Neutrophil-to-lymphocyte ratio as a predictor of postoperative morbidity in patients with distal cholangiocarcinoma , 2018, Molecular and clinical oncology.

[6]  T. Utsunomiya,et al.  Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study , 2018, Annals of Surgical Oncology.

[7]  Jin‐Young Jang,et al.  of the pancreas , 2017 .

[8]  J. Cameron,et al.  Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2017, Annals of surgery.

[9]  H. Baba,et al.  The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms , 2015, Journal of Gastrointestinal Surgery.

[10]  Fiona Powrie,et al.  Emerging cytokine networks in colorectal cancer , 2015, Nature Reviews Immunology.

[11]  Zongguang Zhou,et al.  Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis , 2015, Scientific Reports.

[12]  T. Yamanaka,et al.  Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma: A Retrospective Analysis , 2013, Annals of surgery.

[13]  G. Dimitrakopoulos,et al.  The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. , 2013, American journal of surgery.

[14]  Jin-Young Jang,et al.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[15]  H. Yamaue,et al.  The Carcinoembryonic Antigen Level in Pancreatic Juice and Mural Nodule Size Are Predictors of Malignancy for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2012, Annals of surgery.

[16]  Walter G. Park,et al.  Diagnostic Performance of Cyst Fluid Carcinoembryonic Antigen and Amylase in Histologically Confirmed Pancreatic Cysts , 2011, Pancreas.

[17]  M. W. Büchler,et al.  Preoperative tissue diagnosis for tumours of the pancreas , 2009, The British journal of surgery.

[18]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[19]  K. Mizumoto,et al.  Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas , 2005, Journal of Gastroenterology.

[20]  Y. Hirooka,et al.  Autoimmune Hepatitis Associated with Celiac Disease in Childhood: Report of Two Cases , 2003, Journal of gastroenterology and hepatology.

[21]  Qiang Sun,et al.  Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. , 2015, Biomedical reports.

[22]  T. Ohtsuka,et al.  An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. , 2012, Surgery.